Mres Clinical Drug Development

The Clinical Drug Development MRes offered by University College London (UCL) is a one-year full-time course that is uniquely designed to provide students with a scientific understanding of the molecular and cellular biology that underpins the development of novel drugs. It also provides insight into how clinical trial protocols are designed and regulatory affairs affecting the drug development process. Course Content: The curriculum offers a substantial research component and vocational training in research methods and statistics. It includes modules on Drug Discovery and Pharma, Advanced Clinical Pharmacology, Novel Drug Targets, Research & Ethics, and Clinical Study Design and Safety in Clinical Trials. Key Modules: The key modules of the course are Immuno-oncology, Antibody Conjugates, Medicinal Cannabis, Orphan Drugs in Neurology, Drug Infusion and Special Cases. There's also a substantial research project which allows students to gain practical experience in a specialist area. Accreditations: No specific accreditation information is provided for this course.Future Careers: As this course provides comprehensive training in the field of drug discovery, clinical research, and related areas, it has a wide scope for future career paths in academia, pharmaceutical industry, or clinical trials. Graduates can find opportunities in teaching, research-based roles, drug development, and managerial roles in the pharmaceutical industry.For more information on this course, please visit the official course page.